LSCV Interview
Investment
Jul 26, 2022

LSCV Interview

The team of FluoSphera explains how our technology is used as a powerful alternative to animal experimentation

The ultimate goal of alternatives to animal experimentation is not simply to provide models as relevant as animals, but much better! This is the best way to develop more potent and safer therapies for patients!

In this video (with also a teaser) made by LSCV, the team of FluoSphera explains how our technology is used as a powerful alternative to animal experimentation for drug discovery and for toxicity testing.

Gregory Segala

Gregory has a Ph.D. in Oncology, he discovered the target of a human tumor suppressor metabolite, and identified new target for breast cancer treatment. He is a co-inventor of the multi-tissue systems of FluoSphera.

FluoSphera's technology is a multi-organoid system that combines encapsulated tissues to mimic the complex human system, enabling reliable in vitro drug discovery.

Enter your email for an exclusive trial
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.